Greetings, advocates! This month’s Washington update covers how Congress’s tax proposals affect rheumatology, the ACR’s plan to fight Medicare’s adjustments to Part B drug costs in MIPS, the good news of Medicare’s new individualized biosimilar reimbursement, advances in the rheumatology-specific Alternative Payment Model and developments in Congress’s awareness about the perilous pharmacy benefit manager system….
Biosimilars Great Debate: To Switch or Not?
SAN DIEGO—Should patients with rheumatic diseases switch from a biologic to its biosimilar? At the 2017 ACR/ARHP Annual Meeting’s Great Debate, held Nov. 5, two rheumatologists argued whether to switch or stay put based on safety, efficacy and potential cost savings. First to the podium to make the case for switching, Jonathan Kay, MD, tweaked…
Lower Medicaid Fees Linked to Scarcer Primary Care Appointments
(Reuters Health)—When the fees paid to healthcare providers by Medicaid go up, appointments with primary care doctors suddenly become more available to Medicaid beneficiaries – and the opposite happens when fees go down, according to a recent U.S. study. Researchers found that, overall, every $10 change up or down in the Medicaid fees paid to…
Nearly 1.5 Million People Signed Up for Obamacare Plans So Far
WASHINGTON (Reuters)—More than 800,000 people signed up for Obamacare individual health insurance plans in the second week of open enrollment, U.S. government health officials said on Wednesday, bringing the total number of sign-ups to nearly 1.5 million so far. There is particular scrutiny of how Affordable Care Act programs are faring after a year in…
Senate Finance Chairman Revises Tax Plan to End Obamacare Mandate
WASHINGTON (Reuters)—The head of the U.S. Senate Finance Committee proposed major changes to a Republican tax reform plan, adding a repeal of Obamacare’s health insurance mandate and making corporate tax cuts permanent while ending individual cuts in 2025. In a statement late on Tuesday, committee chairman Orrin Hatch said the proposed changes would also slightly…
The Rheumatologist Selects Dr. Philip Seo as Physician Editor
For the last 20 years, Philip Seo, MD MHS, has trained, worked and conducted research at Johns Hopkins University. As an associate professor of medicine, he also serves in two other roles: as the director of the university’s fellowship training program and director of its vasculitis center. After graduating medical school from Columbia University in…
What You Need to Know about the New Medicare Card Project
Beginning in April 2018, Medicare patients will receive newly designed Medicare identification cards that replace their Social Security numbers (SSNs) with unique, randomly assigned, alphanumeric identification numbers. The Centers for Medicare & Medicaid Services (CMS) is making the change to protect patients 65 and older from exposing their SSNs in efforts to “help prevent fraud,…
Trump to Tap Ex-Pharma Executive Azar as U.S. Health Secretary
WASHINGTON (Reuters)—President Donald Trump on Monday said he will nominate former pharmaceutical executive and industry lobbyist Alex Azar to serve as U.S. Health and Human Services secretary, saying Azar would push to lower the price of medicines. If confirmed, Azar also would take the lead in implementing Trump’s campaign promise to dismantle the Affordable Care…
Rheumatologist’s Ping-Pong Prowess Sharpens His Skills with Patients
Roughly 15 years ago, Steven K. Magid, MD, rheumatologist and chief medical information officer at the Hospital for Special Surgery (HSS) in N.Y., attended a social event for hospital employees. While chatting with other physicians, nurses, and lab techs, he watched one of his colleagues slaughter her opponents at Ping-Pong. “She was very skilled,” recalls Dr. Magid,…
Fellows’ Forum: 7 Tips to Successfully Manage Upward During Fellowship
During the two or three short years of a rheumatology fellowship, there is so much to learn: the subtle art of the musculoskeletal examination, the intricacies of the immune system and the indications for a dizzyingly increasing array of new medications, to name just a few topics. One topic that you rarely hear about, but…
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 229
- Next Page »